Orrick Advises VNV Global on Its Investment in Babylon’s $100 Million Financing


We have advised VNV Global on its investment in digital healthcare service provider Babylon’s $100 million financing round. VNV’s $35 million investment will primarily be in the form of convertible notes which are expected to convert into equity in connection with Babylon’s next equity financing. 

The full $100 million invested in Babylon is through Global Health Equity AB, a newly established company within the VNV Global group. Babylon will use the funding to continue to invest in its international expansion, as well as increase its focus on value-based care and product development. 

Orrick previously advised VNV on its 2019 investment in Babylon, along with Kinnevik, which, at the time, was one of the largest fundraisings in UK venture capital history. The Orrick team advising VNV includes Shawn Atkinson, Chris Perry, Jonathan Rosen, Bridget Winters and Rebecca Kellner.